238 related articles for article (PubMed ID: 33843197)
1.
Durmusoglu D; Al'Abri IS; Collins SP; Cheng J; Eroglu A; Beisel CL; Crook N
ACS Synth Biol; 2021 May; 10(5):1039-1052. PubMed ID: 33843197
[No Abstract] [Full Text] [Related]
2. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.
Jin Y; Yu S; Liu JJ; Yun EJ; Lee JW; Jin YS; Kim KH
Microb Cell Fact; 2021 Aug; 20(1):160. PubMed ID: 34407819
[TBL] [Abstract][Full Text] [Related]
3. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
Sen S; Mansell TJ
Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
[TBL] [Abstract][Full Text] [Related]
4. Microbiome Engineering Using Probiotic Yeast:
Kim J; Atkinson C; Miller MJ; Kim KH; Jin YS
Microbiol Spectr; 2023 Aug; 11(4):e0078023. PubMed ID: 37436157
[TBL] [Abstract][Full Text] [Related]
5. Programming Probiotics: Diet-Responsive Gene Expression and Colonization Control in Engineered
Durmusoglu D; Haller DJ; Al'Abri IS; Day K; Sands C; Clark A; San-Miguel A; Vazquez-Uribe R; Sommer MOA; Crook NC
ACS Synth Biol; 2024 Jun; 13(6):1851-1865. PubMed ID: 38787439
[No Abstract] [Full Text] [Related]
6. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
[TBL] [Abstract][Full Text] [Related]
7. A Mutation in
Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
[TBL] [Abstract][Full Text] [Related]
8. Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing L-fucose, a mammalian mucin component.
Kim J; Cheong YE; Yu S; Jin YS; Kim KH
Microb Cell Fact; 2022 Oct; 21(1):204. PubMed ID: 36207743
[TBL] [Abstract][Full Text] [Related]
9. Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract.
Hedin KA; Rees VE; Zhang H; Kruse V; Vazquez-Uribe R; Sommer MOA
Sci Rep; 2022 May; 12(1):8862. PubMed ID: 35614092
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Engineering of Probiotic Saccharomyces boulardii.
Liu JJ; Kong II; Zhang GC; Jayakody LN; Kim H; Xia PF; Kwak S; Sung BH; Sohn JH; Walukiewicz HE; Rao CV; Jin YS
Appl Environ Microbiol; 2016 Apr; 82(8):2280-2287. PubMed ID: 26850302
[TBL] [Abstract][Full Text] [Related]
11. Improving therapeutic protein secretion in the probiotic yeast Saccharomyces boulardii using a multifactorial engineering approach.
Durmusoglu D; Al'Abri I; Li Z; Islam Williams T; Collins LB; Martínez JL; Crook N
Microb Cell Fact; 2023 Jun; 22(1):109. PubMed ID: 37287064
[TBL] [Abstract][Full Text] [Related]
12. Enhancing probiotic impact: engineering
de Carvalho BT; Subotić A; Vandecruys P; Deleu S; Vermeire S; Thevelein JM
Appl Environ Microbiol; 2024 Jun; 90(6):e0032524. PubMed ID: 38752748
[No Abstract] [Full Text] [Related]
13. New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii.
Samakkarn W; Vandecruys P; Moreno MRF; Thevelein J; Ratanakhanokchai K; Soontorngun N
Appl Microbiol Biotechnol; 2024 Jan; 108(1):153. PubMed ID: 38240846
[TBL] [Abstract][Full Text] [Related]
14. A Tunable and Expandable Transactivation System in Probiotic Yeast
Kwak S; Mahmud B; Dantas G
ACS Synth Biol; 2022 Jan; 11(1):508-514. PubMed ID: 34939781
[TBL] [Abstract][Full Text] [Related]
15. Saccharomyces boulardii promoters for control of gene expression in vivo.
Sands C; Hedin KA; Vazquez-Uribe R; Sommer MOA
Microb Cell Fact; 2024 Jan; 23(1):16. PubMed ID: 38185666
[TBL] [Abstract][Full Text] [Related]
16. Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.
Douradinha B; Reis VC; Rogers MB; Torres FA; Evans JD; Marques ET
Bioengineered; 2014; 5(1):21-9. PubMed ID: 24013355
[TBL] [Abstract][Full Text] [Related]
17. Heterologous Expression of the Leuconostoc Bacteriocin Leucocin C in Probiotic Yeast Saccharomyces boulardii.
Li R; Wan X; Takala TM; Saris PEJ
Probiotics Antimicrob Proteins; 2021 Feb; 13(1):229-237. PubMed ID: 32567021
[TBL] [Abstract][Full Text] [Related]
18. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
[TBL] [Abstract][Full Text] [Related]
19. Saccharomyces boulardii and Candida albicans experimental colonization of the murine gut.
Samonis G; Falagas ME; Lionakis S; Ntaoukakis M; Kofteridis DP; Ntalas I; Maraki S
Med Mycol; 2011 May; 49(4):395-9. PubMed ID: 21077734
[TBL] [Abstract][Full Text] [Related]
20. Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces boulardii.
Fu J; Liu J; Wen X; Zhang G; Cai J; Qiao Z; An Z; Zheng J; Li L
Probiotics Antimicrob Proteins; 2023 Aug; 15(4):967-982. PubMed ID: 35608794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
